Rosalie A. Scholtes

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial

Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar et al. · Diabetes Care · 2020 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from <scp>DAPASALT</scp> and <scp>DIAMOND</scp>

Taha Sen, Rosalie A. Scholtes, Peter J. Greasley et al. · Diabetes Obesity and Metabolism · 2022 · 33 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet

Rosalie A. Scholtes, Marcel H.A. Muskiet, Michiel J.B. van Baar et al. · Kidney International Reports · 2022 · 29 citations · Full text

Medicine, Endocrinology, Nephrology +17

The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis

Rosalie A. Scholtes, Daniël H. van Raalte, Ricardo Correa‐Rotter et al. · Diabetes Obesity and Metabolism · 2019 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial

Rosalie A. Scholtes, Charlotte M. Mosterd, Anne C. Hesp et al. · Diabetes Obesity and Metabolism · 2022 · 11 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17